Basecamp Research has raised $140 million (£106m) in Series C financing to continue developing its AI-designed medicines. Basecamp’s ambition is to develop cures for diseases that remain incurable by designing medicines that reprogram the body to repair itself.  The company combines frontier AI models trained on proprietary biological data with technology for writing DNA sequences … Continue reading Basecamp Research raises £100m+ to ‘cure incurable diseases’